Home >> Life Sciences >> Healthcare

Smoking Addiction - Pipeline Review, H1 2017

Published: Jun-2017 | Format: PDF | Global Markets Direct | Number of pages: 86 | Code: MRS - 139811

Smoking Addiction - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smoking Addiction - Pipeline Review, H1 2017, provides an overview of the Smoking Addiction (Central Nervous System) pipeline landscape.

In smoking addiction, people experience an uncontrollable dependence on cigarettes, which on stopping will cause severe mental, emotional or physical reactions. People addicted to smoking develop tolerance to nicotine. Nicotine acts on acetylcholine receptors causing the body to react to nicotine at these receptors in the same manner as it responds to acetylcholine. This leads to alterations in the activity and physiological functions of many brain systems. This causes structural and functional changes in the brains of smokers. Upon sudden nicotine withdrawal, the brain and other parts of the body get disturbed, leading to a condition called withdrawal syndrome. The body usually takes time to function in the absence of nicotine. The effects of smoking withdrawal stem from the lack of nicotine that can be overcome by nicotine replacement therapies such as the use of nicotine patch or nicotine chewing gum.  

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Smoking Addiction - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Smoking Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Smoking Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Smoking Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 5, 8, 6, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively.

Smoking Addiction (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Smoking Addiction (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Smoking Addiction (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Smoking Addiction (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Smoking Addiction (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 
- The pipeline guide reviews latest news related to pipeline therapeutics for Smoking Addiction (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Smoking Addiction (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Smoking Addiction (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Smoking Addiction - Overview
Smoking Addiction - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Smoking Addiction - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Smoking Addiction - Companies Involved in Therapeutics Development
Aradigm Corp
Bionex Pharmaceuticals LLC
Bioprojet SCR
CoMentis Inc
Embera NeuroTherapeutics Inc
Invion Ltd
Jeil Pharmaceutical Co Ltd
Johnson & Johnson
Lotus Pharmaceutical Co Ltd
NAL Pharmaceuticals Ltd
Pfizer Inc
Rock Creek Pharmaceuticals, Inc.
Selecta Biosciences Inc
Sopharma AD
Zynerba Pharmaceuticals Inc
Smoking Addiction - Drug Profiles
(metyrapone + oxazepam) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AKR-214 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
amitifadine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Anatabine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AT-1001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BP-1.4979 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cytisine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GTS-21 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
JLP-1603 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
JNJ-39393406 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nadolol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NFL-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NIC-7DT - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nicotine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nicotine bitartrate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nicotine bitartrate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PF-06413367 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SEL-068 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SEL-070 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Agonize Alpha 4Beta 2 and Alpha 6Beta 2 Neuronal Nicotinic Receptor for Smoking Cessation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize Cannabinoid Receptor for Smoking Addiction - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit Sodium Dependent Dopamine, Noradrenaline and Serotonin Transporters for Appetite Suppression and Smoking Cessation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Agonize Neuronal Nicotinic Acetylcholine Receptor for Smoking Cessation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize CHRNA3 and CHRNB4 for Smoking Cessation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize CHRNB2 and CHRNA4 for Smoking Cessation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
URB-694 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Smoking Addiction - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Smoking Addiction - Dormant Projects
Smoking Addiction - Discontinued Products
Smoking Addiction - Product Development Milestones
Featured News & Press Releases
May 11, 2017: Selecta Biosciences Commences Dosing in Phase 1 Clinical Trial of Nicotine Vaccine for Smoking Cessation and Relapse Prevention
Mar 08, 2017: Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Cytisine Symposium at the Annual Society for Research in Nicotine and Tobacco Conference ("SRNT")
Oct 20, 2016: OWC Pharmaceutical Research Completes Development of Its Medical Cannabis Sublingual Tablet
Nov 17, 2015: Invion Phase 2 Smoking Cessation Data: Results of Ongoing Analysis
Oct 05, 2015: Invion Successfully Completes Phase 2 Study of INV102 to Aid Smoking Cessation
Jun 29, 2015: Invion completes dosing in key phase II clinical trial of oral INV102 in smoking cessation
Feb 02, 2015: Invion completes enrolment in its phase II trial of oral INV102 (nadolol) in smoking cessation
Jan 19, 2015: Invion Announces Positive Interim Data from Its Phase II Clinical Trial of Oral Inv102 (nadolol) in Smoking Cessation
Jul 01, 2014: Embera NeuroTherapeutics to Receive Grant for Clinical Trial Through New Crowd Funding Platform
Jan 29, 2014: FDA clears path for “Smoking Cessation” clinical trial of INV102 (nadolol)
Nov 11, 2013: Change to FDA reviewing division for smoking cessation clinical trial
Jul 22, 2013: INVION ANNOUNCES COMMENCEMENT OF PHASE II CHRONIC BRONCHITIS CLINICAL TRIAL
Dec 19, 2012: Invion Provides Update On INV102 Phase II Clinical Programs
Oct 17, 2012: Nabi Biopharma's Phase II Study Of NicVAX In Combination With Varenicline Does Not Meet Primary Endpoint
Mar 16, 2012: Embera And Collaborators Publish Paper In Psychopharmacology Supporting EMB-001 For Smoking Cessation
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

Global Head Lice Infestation Drug Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 78 | Code : MRS-141299 | 2050

Summary Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head Lice Infestation Drug is to kill lice or kill eggs. The Global Head Lice Infestation Drug market is estimated to reach 563.1 Million USD in 2017. On the basis of region, North America is the largest market segment of Head Lice Infestation Drug, follo Read more

Global Ambulatory Surgery Center (ASC) Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 87 | Code : MRS-141298 | 2490

Summary Ambulatory surgery centers, or ASCs, are facilities where surgeries that do not require hospital admis- sion are performed. ASCs provide cost-effective services and a convenient environment that is less stressful than what many hospitals can offer. The Global Ambulatory Surgery Center (ASC) market is estimated to reach 80.2 Billion USD in 2017. On the basis of region, North America is the largest market segment of Ambulatory Surgery Center (ASC), followed by Europe and Asia. In the Read more

Global Pulmonary Function Testing Systems Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 79 | Code : MRS-141198 | 2380

Summary The Global Pulmonary Function Testing Systems market is estimated to reach xxx Million USD in 2017. In the report, HeyReport says Hospitals dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major pro Read more

Global Colposcopy Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 87 | Code : MRS-141197 | 2680

Summary Colposcopy is a medical diagnostic procedure to examine an illuminated, magnified view of the cervix and the tissues of the vagina and vulva. Many premalignant lesions and malignant lesions in these areas have discernible characteristics which can be detected through the examination. It is done using a colposcopy, which provides an enlarged view of the areas, allowing the colposcopies to visually distinguish normal from abnormal appearing tissue and take directed biopsies for furthe Read more

Global Powered Surgical Handpieces Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 74 | Code : MRS-141196 | 2110

Summary The Powered Surgical Handpieces is an instrument that uses air or electricity to generate a rotary cutting motion, similar to how a drill operates. The Powered Surgical Handpieces offer power and performance for spine, cranial, ENT, orthopaedic, and other surgical procedures. The Global Powered Surgical Handpieces market is estimated to reach xxx Million USD in 2017. In the report, HeyReport says Cardiothoracic dominates the largest Application share in 2017. The objective of repor Read more

Global Ceiling-mounted Supply Units Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 79 | Code : MRS-141195 | 2330

Summary Ceiling-mounted supply units help design needs-based workstations in the OR, ICU, Emergency/Trauma and other departments in the hospital. The Global Ceiling-mounted Supply Units market is estimated to reach xxx Million USD in 2017. In the report, HeyReport says Surgery dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors infl Read more

Global Surgical Robots Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 74 | Code : MRS-141194 | 2110

Summary Surgical robot can be controlled through computer program to assist surgery. A surgical robot t allows surgeons greater access to areas under operation using more precise and less invasive methods. The global Surgical Robots market is estimated to reach xxx Million USD in 2017. In the report, HeyReport says General Surgery dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and reg Read more

Global Breathing Machines Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 91 | Code : MRS-141193 | 2750

Summary A breathing machine is a piece of equipment that facilitates breathing in the case of low oxygen levels in the blood stream. It aids the body to overcome the inability to breath normally, such as during respiratory failure. Many people suffer from afflictions such as asthmatic conditions, lung cancer and chronic obstructive lung disease. Breathing machines help the victim of lung problems carry on a more normal life by aiding the person as needed. From oxygen concentrators to ventil Read more

Global Digital X-ray Systems Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 91 | Code : MRS-141192 | 2750

Summary Digital X-Ray Systems is the electronic capture of an X-ray exposure. The exposure is captured in a device that converts the X-rays to a digital signal, which is then represented on a viewing monitor for diagnosis. An image from a Digital X-ray System that appears on a viewing monitor may have come from one of two technologies, namely Computed Radiography (CR) and Direct Digital Radiography (DR/ DDR). The Global Digital X-ray Systems market is estimated to reach xxx Million USD in 2 Read more

Global Medical Manifolds Market Research 2011- 2022

Jun-2017 | HeyReport | Pages : 72 | Code : MRS-141191 | 2080

Summary Medical Stopcock Manifold is an accessory that controls the fluid flow and monitors the pressure used in hemodynamic diagnostic and therapeutic procedures. The Global Medical Manifolds market is estimated to reach xxx Million USD in 2017. In the report, HeyReport says Interventional Cardiology dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the conte Read more

Single User | $(USD)2000 View Pricing